Mizuho Has Lowered Expectations for Sarepta Therapeutics (NASDAQ:SRPT) Stock Price
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) had its target price lowered by Mizuho from $85.00 to $40.00 in a report issued on Wednesday,Benzinga reports. The firm currently has an “outperform” rating on the biotechnology company’s stock. Mizuho’s price target indicates a potential upside of 92.59% from the company’s current price. A number of other […]
Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) had its target price lowered by Mizuho from $85.00 to $40.00 in a report issued on Wednesday,Benzinga reports. The firm currently has an “outperform” rating on the biotechnology company’s stock. Mizuho’s price target indicates a potential upside of 92.59% from the company’s current price. A number of other […]
